These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 24081206)

  • 1. Area under the curve of tacrolimus using microsampling devices: towards precision medicine in solid organ transplantation?
    Couette A; Tron C; Golbin L; Franck B; Houssel-Debry P; Frouget T; Morin MP; Brenier H; Rayar M; Verdier MC; Vigneau C; Chemouny J; Lemaitre F
    Eur J Clin Pharmacol; 2023 Nov; 79(11):1549-1556. PubMed ID: 37725122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune responsiveness in stable kidney transplantation patients: Complete inhibition of T-cell proliferation but residual T-cell activity during maintenance immunosuppressive treatment.
    In 't Veld AE; Eveleens Maarse BC; Juachon MJ; Meziyerh S; de Vries APJ; van Rijn AL; Feltkamp MCW; Moes DJAR; Burggraaf J; Moerland M
    Clin Transl Sci; 2024 Jun; 17(6):e13860. PubMed ID: 38923308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative carcinogenicity of tacrolimus
    Liu D; Youssef MM; Grace JA; Sinclair M
    World J Hepatol; 2024 Apr; 16(4):650-660. PubMed ID: 38689747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Pediatric Covariate Function for CYP3A-Mediated Midazolam Clearance Can Scale Clearance of Selected CYP3A Substrates in Children.
    Brussee JM; Krekels EHJ; Calvier EAM; Palić S; Rostami-Hodjegan A; Danhof M; Barrett JS; de Wildt SN; Knibbe CAJ
    AAPS J; 2019 Jun; 21(5):81. PubMed ID: 31250333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of limited sampling strategies for the estimation of mycophenolic acid area under the curve in adult kidney and liver transplant recipients receiving concomitant enteric-coated mycophenolate sodium and tacrolimus.
    Pawinski T; Luszczynska P; Durlik M; Majchrzak J; Baczkowska T; Chrzanowska M; Sobiak J; Glyda M; Kuriata-Kordek M; Kamińska D; Krajewska M; Klinger M
    Ther Drug Monit; 2013 Dec; 35(6):760-9. PubMed ID: 24192641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which is more suitable for kidney transplantation at the early post-transplantation phase in China - low dosing or standard dosing of enteric-coated mycophenolate sodium?
    Ding C; Xue W; Tian P; Ding X; Pan X; Xiang H; Tian X; Li Y; Zheng J
    Int J Clin Pract Suppl; 2014 Apr; (181):10-6. PubMed ID: 24673714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics, efficacy, and safety of mycophenolate mofetil in combination with standard-dose or reduced-dose tacrolimus in liver transplant recipients.
    Nashan B; Saliba F; Durand F; Barcéna R; Herrero JI; Mentha G; Neuhaus P; Bowles M; Patch D; Bernardos A; Klempnauer J; Bouw R; Ives J; Mamelok R; McKay D; Truman M; Marotta P
    Liver Transpl; 2009 Feb; 15(2):136-47. PubMed ID: 19177449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of mycophenolic acid and its phenolic-glucuronide and ACYl glucuronide metabolites in stable thoracic transplant recipients.
    Ting LS; Partovi N; Levy RD; Riggs KW; Ensom MH
    Ther Drug Monit; 2008 Jun; 30(3):282-91. PubMed ID: 18520599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant.
    Pawinski T; Durlik M; Szlaska I; Urbanowicz A; Majchrnak J; Gralak B
    J Clin Pharm Ther; 2006 Feb; 31(1):27-34. PubMed ID: 16476117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus exposure and mycophenolate pharmacokinetics and pharmacodynamics early after liver transplantation.
    Sæves I; Line PD; Bremer S; Vethe NT; Tveit RG; Meltevik TJ; Bergan S
    Ther Drug Monit; 2014 Feb; 36(1):46-53. PubMed ID: 24081206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Optimal immunosuppressive therapy based on pharmacokinetics and pharmacodynamics of antimetabolites in clinical practice].
    Naito T
    Yakugaku Zasshi; 2010 Dec; 130(12):1695-700. PubMed ID: 21139397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic, pharmacodynamic, and outcome investigations as the basis for mycophenolic acid therapeutic drug monitoring in renal and heart transplant patients.
    Shaw LM; Korecka M; DeNofrio D; Brayman KL
    Clin Biochem; 2001 Feb; 34(1):17-22. PubMed ID: 11239510
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.